Study Evaluating SKI-606 Administered to Healthy Subjects

Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SKI-606 Administered Orally to Healthy Subjects

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00406406

Enrollment

Unknown

Registered

2006-12-04

Start date

2006-11-30

Completion date

2007-08-31

Last updated

2007-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

Safety and tolerability of SKI-606 in healthy subjects; the influence of food intake on the same.

Interventions

DRUGSKI-606

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

18 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* Healthy

Design outcomes

Primary

Measure	Time frame
Pharmacokinetics; safety and tolerability; influence of food.	—

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026